Friday's big stock stories: What’s likely to move the market in the next trading session

Friday's big stock stories: What’s likely to move the market in the next trading session

Stocks slid on Thursday as Fed Chair Jerome Powell signaled that policymakers don’t need to be in a hurry to cut rates. Here’s what’s on CNBC’s radar Friday. Source link Read more »
Diversify away from the growth concentration in the S&P 500, says Bill Nygren

Diversify away from the growth concentration in the S&P 500, says Bill Nygren

There are too many investors in the so-called Magnificent Seven and it’s time to move away from them, according to value investor Bill Nygren. While there has been some rotation out of... Read more »
Dividend-paying health-care stocks could be in early days of a rally

Dividend-paying health-care stocks could be in early days of a rally

It’s time to step back into health-care stocks, according to Wolfe Research. The sector was one of the worst performing over the past month, pulling back over 4% from September to October,... Read more »
Merck says experimental RSV treatment protected infants in trial

Merck says experimental RSV treatment protected infants in trial

The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021. Andrew Kelly | Reuters Merck on Thursday said its experimental treatment designed to... Read more »
Pfizer is betting big on cancer drugs after Covid decline

Pfizer is betting big on cancer drugs after Covid decline

Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid.  Now, the company is betting on cancer drugs to help it regain its footing after a rocky year... Read more »
Big pharma Merck, Bristol Myers, J&J prepare to lose revenue

Big pharma Merck, Bristol Myers, J&J prepare to lose revenue

The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat... Read more »
Merck, J&J CEOs agree to testify in Senate hearing on drug prices

Merck, J&J CEOs agree to testify in Senate hearing on drug prices

Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol on Thursday, January 25, 2024, on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug... Read more »
Medicare drug price negotiations what’s ahead in 2024

Medicare drug price negotiations what’s ahead in 2024

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty... Read more »